Did you know that there's more med spas than McDonald's?

For aesthetic clinic owners, founders, and medical directors: I advise on how to break free from commodity treatments and low-margin price wars. We restructure the clinical offering around high-ticket, high-retention sexual wellness, HRT, and regenerative protocol stacks—deploying the exact operational and clinical velocity blueprint that scaled RevitalyzeMD onto the Inc. 5000 list of America’s fastest-growing private companies in consecutive years (2025 and 2026).

For funds and operators: I conduct clinical, pharmacological, and scientific diligence on longevity, sexual wellness, regenerative medicine, and precision health deals. I assess the strength of the underlying biological mechanisms, the credibility of claims against real clinical data, and whether the product or protocol will survive contact with a practicing physician who understands the literature. I tell you what the deck won't.

Boards need one voice in the room that has actually practiced the medicine the company is building around. I bring 20+ years of high-acuity Emergency Medicine clinical judgment, pharmacology depth, and enterprise governance to board service, product direction, and patient safety risk management. Having founded and scaled an active, multi-million dollar Inc. 5000 medical enterprise, I translate between what laboratory papers claim, what regulators will accept, and what patients and clinicians actually experience.

For companies and emerging brands that need clinical and scientific counsel without a board seat: I advise on clinical evidence strategy, provider adoption, protocol design, and regulatory-adjacent positioning. As the host of the SexMD Podcast, a frequent broadcast media expert, and keynote leader for women's and men's health symposiums (including hosting the regional premiere panel for The (M) Factor 2: Before The Pause at the JTV Auditorium), I evaluate a company's science and also tell you whether providers and consumers will understand and adopt it.